Author

H. Arslan

h-index 1 View on Semantic Scholar

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Circular RNAs in Breast Cancer Progression and their Potential Clinical Applications

Breast cancer (BC) is the most prevalent malignant tumor among women globally. It is a biologically heterogeneous disease driven by complex genetic and epigenetic alterations that influence tumor initiation, progression, metastasis, and therapeutic response. Among the epigenetic regulators, non-coding RNAs (ncRNAs), pa...

A. Abuaisha, H. Arslan, Emir Nekay et al. · Konuralp Tip Dergisi · 0 citations

Open access Sep 2026

Melatonin Differentially Modulates Temozolomide Responses in Glioblastoma and Endothelial Cells: Associations with Global DNA Methylation and Cortistatin Levels

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and remains highly resistant to current therapeutic strategies. Temozolomide (TMZ) is a standard chemotherapeutic agent used in GBM treatment; however, intrinsic and acquired resistance limits its efficacy. This study investigated treatment-associa...

G. Gundogan, A. Yurttaş, Y. Oltulu et al. · Current Issues in Molecular... · 0 citations

Jul 2026

Carvacrol induces apoptosis, modulates oxidative stress, and promotes G0/G1 cell cycle arrest in colorectal cancer cells.

It is demonstrated that carvacrol effectively inhibits CRC growth while exerting limited effects on normal colon fibroblasts, which support the further investigation of carvacrol as a potential complementary therapeutic agent for CRC.

A. Abuaisha, H. Arslan, Emir Nekay et al. · Molecular and Cellular Bioch... · 0 citations